Evidence map›Paper›PMID 34521672›Full record

ArticleBMJ open2021

Evaluating associations of joint swelling, joint stiffness and joint pain with physical activity in first-degree relatives of patients with rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA), a prospective cohort study.

Jan M Hughes-Austin, Joachim H Ix, Samuel R Ward, Michael H Weisman, James R ODell, Ted R Mikuls, Jane H Buckner, Peter K Gregersen, Richard M Keating, M Kristen Demoruelle and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Jan M Hughes-AustinDepartment of Orthopaedic Surgery, University of California, San Diego, La Jolla, California, USA jhughesaustin@health.ucsd.edu.ORCID 0000-0002-7255-274X
Joachim H IxDepartment of Medicine, Division of Nephrology-Hypertension, University of California, San Diego, La Jolla, California, USA.
Samuel R WardDepartment of Orthopaedic Surgery, University of California, San Diego, La Jolla, California, USA.
Michael H WeismanSchool of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
James R ODellCollege of Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Ted R MikulsCollege of Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Jane H BucknerTranslational Research Institute, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.ORCID 0000-0002-9005-1885
Peter K GregersenRoberts S Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, New York, USA.
Richard M KeatingDivision of Rheumatology, Scripps Green Hospital, La Jolla, California, USA.
M Kristen DemoruelleSchool of Medicine, Department of Rheumatology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.
Kevin D DeaneSchool of Medicine, Department of Rheumatology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.
V Michael HolersSchool of Medicine, Department of Rheumatology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.
Jill M NorrisDepartment of Epidemiology, Colorado School of Public Health, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.
Center for Rheumatology · USUniversity of California San Diego · USUniversity of Nebraska Medical Center · USCedars-Sinai Medical Center · USColorado School of Public Health · USFeinstein Institute for Medical Research · USScripps Green Hospital · USTranslational Research Institute · AU

Funding

Virginia Mason/UCHSC Autoimmune Prevention CenterU19AI050864 · NIAID · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 2001 to 2011
$29.2M
RA-Related Autoantibodies in Healthy FDR of RA PatientsR01AR051394 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI NORRIS, JILL M · 2005 to 2011
$3.0M
Antibodies to Citrullinated Protein Antigens, CVD and Bone Disease in MESAK01HL122394 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HUGHES-AUSTIN, JAN MARIE · 2015 to 2019
$836k
Mentored Patient Oriented Research in Kidney DiseaseK24DK110427 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IX, JOACHIM H · 2016 to 2020
$780k
NHLBI NIH HHS K01 HL122394NIAID NIH HHS U19 AI050864NIAMS NIH HHS R01 AR051394NIDDK NIH HHS K24 DK110427
6 · The paper itself

Abstract

objectivePhysical activity (PA) in preclinical rheumatoid arthritis (RA) is associated with lower RA risk and disease severity. As joint signs and symptoms of inflammatory arthritis serve as a barrier to PA in RA, it is important to consider whether they affect PA in the time prior to RA. Therefore, we investigated whether joint swelling, stiffness or pain were associated with PA in first-degree relatives (FDRs) of patients with RA, a population at higher risk for future RA.

designProspective study design.

settingWe recruited FDRs of patients with RA from academic centres, Veterans' hospitals and rheumatology clinics or through responses to advertising from six sites across the USA.

participantsWe evaluated associations of joint stiffness, joint swelling and joint pain with PA time in 268 FDRs with ≥2 visits over an average 1.2 years. Clinicians confirmed joint swelling. Participants self-reported joint stiffness and/or pain. PRIMARY OUTCOME MEASURES: PA during a typical 24-hour day was quantified via questionnaire, weighted to reflect metabolic expenditure, where 24 hours was the minimum PA time. Linear mixed models evaluated associations between symptoms and change in PA over time, adjusting for age, sex, race, body mass index, smoking and RA-related autoantibodies.

resultsAverage weighted PA time was 37±7 hours. In the cross-sectional analysis, PA time was 1.3±0.9 hours higher in FDRs reporting joint pain (p=0.15); and 0.8±1.6 and 0.4±1 hours lower in FDRs with joint swelling (p=0.60) and stiffness (p=0.69), respectively. Longitudinally, adjusting for baseline PA time, baseline symptoms were not significantly associated with changes in PA time. However, on average over time, joint stiffness and pain were associated with lower PA time (p

conclusionBaseline symptoms did not predict future PA time, but on average over time, joint symptoms influenced PA time.

Indexed as

Arthritis, RheumatoidArthralgiaCross-Sectional StudiesExerciseHumansProspective Studiesepidemiologyrehabilitation medicinerheumatology

Identifiers

PMID34521672
PMCPMC8442039
OpenAlexW3199554642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.